In this case, it targets the tissue surrounding your joints called the synovium
By purchasing, you confirm these compounds will be used exclusively for approved in vitro or pre-clinical research purposes
Tumors were harvested, weighed, and assessed via IHC
"Associations of proinflammatory cytokines with the risk of recurrent stroke"
Notably, in the SURMOUNT-1 DXA substudy, visceral fat mass was reduced by 40.1% with tirzepatide compared with 7.3% with placebo [58]
Whether FcRn antagonists in the clinical pipeline may have similar effects and thereby could be viable prophylactic treatment options for viral infection is still an open question, given that they are, in most cases, selected to specifically engage and occlude the binding site of IgG on FcRn